Evidence map›Paper›PMID 39102377›Full record

ArticlePLOS digital health2024

Evaluating the diagnostic and triage performance of digital and online symptom checkers for the presentation of myocardial infarction; A retrospective cross-sectional study.

William Wallace, Calvin Chan, Swathikan Chidambaram, Lydia Hanna, Amish Acharya, Elisabeth Daniels, Pasha Normahani, Rubeta N Matin, Sheraz R Markar, Viknesh Sounderajah and 2 more

Abstract read
In one paragraph

Article in PLOS digital health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

William WallaceDepartment of Surgery & Cancer, Imperial College London, St. Mary's Hospital, London, United Kingdom.ORCID https://orcid.org/0000-0003-1726-2923
Calvin ChanDepartment of Surgery & Cancer, Imperial College London, St. Mary's Hospital, London, United Kingdom.ORCID https://orcid.org/0000-0002-8236-5323
Swathikan ChidambaramDepartment of Surgery & Cancer, Imperial College London, St. Mary's Hospital, London, United Kingdom.
Lydia HannaDepartment of Surgery & Cancer, Imperial College London, St. Mary's Hospital, London, United Kingdom.ORCID https://orcid.org/0000-0002-5477-5085
Amish AcharyaDepartment of Surgery & Cancer, Imperial College London, St. Mary's Hospital, London, United Kingdom.
Elisabeth DanielsDepartment of Surgery & Cancer, Imperial College London, St. Mary's Hospital, London, United Kingdom.
Pasha NormahaniDepartment of Surgery & Cancer, Imperial College London, St. Mary's Hospital, London, United Kingdom.
Rubeta N MatinDepartment of Dermatology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.ORCID https://orcid.org/0000-0002-9695-5412
Sheraz R MarkarSurgical Intervention Trials Unit, Nuffield Department of Surgery, University of Oxford, United Kingdom.
Viknesh SounderajahInstitute of Global Health Innovation, Imperial College London, South Kensington Campus, London, United Kingdom.
Xiaoxuan LiuInstitute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom.
Ara DarziDepartment of Surgery & Cancer, Imperial College London, St. Mary's Hospital, London, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Online symptom checkers are increasingly popular health technologies that enable patients to input their symptoms to produce diagnoses and triage advice. However, there is concern regarding the performance and safety of symptom checkers in diagnosing and triaging patients with life-threatening conditions. This retrospective cross-sectional study aimed to evaluate and compare commercially available symptom checkers for performance in diagnosing and triaging myocardial infarctions (MI). Symptoms and biodata of MI patients were inputted into 8 symptom checkers identified through a systematic search. Anonymised clinical data of 100 consecutive MI patients were collected from a tertiary coronary intervention centre between 1st January 2020 to 31st December 2020. Outcomes included (1) diagnostic sensitivity as defined by symptom checkers outputting MI as the primary diagnosis (D1), or one of the top three (D3), or top five diagnoses (D5); and (2) triage sensitivity as defined by symptom checkers outputting urgent treatment recommendations. Overall D1 sensitivity was 48±31% and varied between symptom checkers (range: 6-85%). Overall D3 and D5 sensitivity were 73±20% (34-92%) and 79±14% (63-94%), respectively. Overall triage sensitivity was 83±13% (55-91%). 24±16% of atypical cases had a correct D1 though for female atypical cases D1 sensitivity was only 10%. Atypical MI D3 and D5 sensitivity were 44±21% and 48±24% respectively and were significantly lower than typical MI cases (p<0.01). Atypical MI triage sensitivity was significantly lower than typical cases (53±20% versus 84±15%, p<0.01). Female atypical cases had significantly lower diagnostic and triage sensitivity than typical female MI cases (p<0.01).Given the severity of the pathology, the diagnostic performance of symptom checkers for correctly diagnosing an MI is concerningly low. Moreover, there is considerable inter-symptom checker performance variation. Patients presenting with atypical symptoms were under-diagnosed and under-triaged, especially if female. This study highlights the need for improved clinical performance, equity and transparency associated with these technologies.

Identifiers

PMID39102377
PMCPMC11299816

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.